129 related articles for article (PubMed ID: 35267493)
1. Deep Learning-Based Pan-Cancer Classification Model Reveals Tissue-of-Origin Specific Gene Expression Signatures.
Divate M; Tyagi A; Richard DJ; Prasad PA; Gowda H; Nagaraj SH
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267493
[TBL] [Abstract][Full Text] [Related]
2. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
[TBL] [Abstract][Full Text] [Related]
3. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
[TBL] [Abstract][Full Text] [Related]
4. Deep learning model accurately classifies metastatic tumors from primary tumors based on mutational signatures.
Zheng W; Pu M; Li X; Du Z; Jin S; Li X; Zhou J; Zhang Y
Sci Rep; 2023 May; 13(1):8752. PubMed ID: 37253775
[TBL] [Abstract][Full Text] [Related]
5. Classification of Cancer Types Using Graph Convolutional Neural Networks.
Ramirez R; Chiu YC; Hererra A; Mostavi M; Ramirez J; Chen Y; Huang Y; Jin YF
Front Phys; 2020 Jun; 8():. PubMed ID: 33437754
[TBL] [Abstract][Full Text] [Related]
6. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
[TBL] [Abstract][Full Text] [Related]
7. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J
Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960
[TBL] [Abstract][Full Text] [Related]
8. Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary.
Hwang J; Lee Y; Yoo SK; Kim JI
Neoplasia; 2024 Jun; 55():101021. PubMed ID: 38943996
[TBL] [Abstract][Full Text] [Related]
9. CancerNet: a unified deep learning network for pan-cancer diagnostics.
Gore S; Azad RK
BMC Bioinformatics; 2022 Jun; 23(1):229. PubMed ID: 35698059
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.
Li Y; Kang K; Krahn JM; Croutwater N; Lee K; Umbach DM; Li L
BMC Genomics; 2017 Jul; 18(1):508. PubMed ID: 28673244
[TBL] [Abstract][Full Text] [Related]
11. A hybrid metaheuristic-deep learning technique for the pan-classification of cancer based on DNA methylation.
Eissa NS; Khairuddin U; Yusof R
BMC Bioinformatics; 2022 Jul; 23(1):273. PubMed ID: 35818034
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis.
Inaki K; Shibutani T; Maeda N; Eppenberger-Castori S; Nicolet S; Kaneda Y; Koyama K; Qiu Y; Wakita K; Murakami M
PLoS One; 2022; 17(9):e0274140. PubMed ID: 36137139
[TBL] [Abstract][Full Text] [Related]
13. Topology preserving stratification of tissue neoplasticity using Deep Neural Maps and microRNA signatures.
Kaczmarek E; Nanayakkara J; Sedghi A; Pesteie M; Tuschl T; Renwick N; Mousavi P
BMC Bioinformatics; 2022 Jan; 23(1):38. PubMed ID: 35026982
[TBL] [Abstract][Full Text] [Related]
14. TOOme: A Novel Computational Framework to Infer Cancer Tissue-of-Origin by Integrating Both Gene Mutation and Expression.
He B; Lang J; Wang B; Liu X; Lu Q; He J; Gao W; Bing P; Tian G; Yang J
Front Bioeng Biotechnol; 2020; 8():394. PubMed ID: 32509741
[TBL] [Abstract][Full Text] [Related]
15. Selecting precise reference normal tissue samples for cancer research using a deep learning approach.
Zeng WZD; Glicksberg BS; Li Y; Chen B
BMC Med Genomics; 2019 Jan; 12(Suppl 1):21. PubMed ID: 30704474
[TBL] [Abstract][Full Text] [Related]
16. RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers.
Jones WD; Michener CM; Biscotti C; Braicu I; Sehouli J; Ganapathi MK; Ganapathi RN
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32156016
[TBL] [Abstract][Full Text] [Related]
17. NetRank Recovers Known Cancer Hallmark Genes as Universal Biomarker Signature for Cancer Outcome Prediction.
Al-Fatlawi A; Afrin N; Ozen C; Malekian N; Schroeder M
Front Bioinform; 2022; 2():780229. PubMed ID: 36304266
[TBL] [Abstract][Full Text] [Related]
18. Tumor type classification and candidate cancer-specific biomarkers discovery via semi-supervised learning.
Chen P; Li Z; Hong Z; Zheng H; Zeng R
Biophys Rep; 2023 Apr; 9(2):57-66. PubMed ID: 37753058
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer classification by regularized multi-task learning.
Hossain SMM; Khatun L; Ray S; Mukhopadhyay A
Sci Rep; 2021 Dec; 11(1):24252. PubMed ID: 34930937
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of Transcriptomic Data for Improved Classification of Patients with Respiratory Diseases of Viral Origin.
Kircher M; Chludzinski E; Krepel J; Saremi B; Beineke A; Jung K
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
